Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Lung Cancer Health Center

Font Size

Gene Test May Help Determine Early Lung Cancer Survival

Test May Help Doctors Decide Which Patients Would Benefit From Chemotherapy After Surgery

Gene-Profiling Lung Tumors continued...

And they think they have succeeded.

So far, researchers have tried out the test in three different patient populations, representing more than 1,800 people with non-squamous, non-small-cell lung cancer, which is the most common type.

The results have been remarkably consistent.

Patients with tumors that had a high-risk profile as measured by the test also had a high rate of early death. About half of those patients were not alive five years after their diagnoses.

About 42% of patients with tumors that were deemed intermediate risk based on their genetic profile were not alive five years after their cancer was discovered.

And 25% to 30% of patients with low-risk tumors had not survived five years later.

The researchers’ results are published in The Lancet.

Will Gene-Profiling Lung Cancers Improve Treatment?

Researchers say it’s not yet clear what this means in terms of treatment.

“That’s the $64,000 question,” Mann says. “We know that certain subsets of patients who undergo surgery will have increased survival if they get chemotherapy after surgery,” he says.

But chemotherapy is not recommended for many stage I non-small-cell lung cancers. Mann thinks that’s because the studies simply haven’t be able to distinguish high-risk from low-risk patients. He thinks the new test could change that.

Other experts agree.

“In my mind, currently, it’s the best of anything I’ve seen, and it’s done in a fashion that could be deployed in the real world,” says John L. Minna, MD, a pulmonary oncologist at the University of Texas Southwestern Medical Center in Dallas.

Minna wrote a commentary on the study but was not involved in the research.

He says with more people getting screening tests for lung cancer, having a better way to distinguish high-risk from low-risk patients will be important for making sure people don’t get too much or too little treatment for their disease.

1 | 2

Today on WebMD

Broken cigarette
Do you know the myths from the facts?
man with a doctor
Our health check will steer you in the right direction.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Lung cancer xray
See it in pictures, plus read the facts.
15 Cancer Symptoms Men Ignore
Lung Cancer Risks Myths and Facts
cancer fighting foods
Improving Lung Cancer Survival Targeted Therapy
Lung Cancer Surprising Differences Between Sexes
Pets Improve Your Health
Vitamin D
Lung Cancer Surgery Options